한국어
미제공
안건의 새로운 내용은 무엇입니까?
English
한국어
미제공
Inspired by Obangsaek: Five New Perspectives
오방색에서 영감을 얻은 다섯 가지 새 관점
New International Companies Speaking Include:
New Korean Companies Speaking Include:
New Topics:
Brand-new sessions covering dual-payload ADCs and degrader antibody conjugates, biomarker selection and preclinical pharmacokinetics, through to streamlined manufacturing and regulatory CMC considerations
Korean Developers Panel Discussion:
New for 2026 comes a Korean ADC Leaders Panel Discussion to discuss and share a roadmap of how South Korea can differentiate its R&D to become the next global powerhouse of ADC development
Pharma Partnering Panel Discussion:
Hear the perspectives on global pharma and biotech partnerships from Pfizer, Eli Lilly, Merck & Co and Remegen to help better position your company for collaboration to gain financial and strategic support to take your candidate through clinical development
Download the Official Agenda to Explore:
- Your One-Stop Forum to Develop First- and Best-in-Class ADC Therapeutics
- Insights from 35+ Korean-Based and International Speakers
- Unrivalled Networking Opportunities with Professionals Working on ADCs, TPD & Induced Proximity, and Bispecifics & T-Cell Engagers
